Modulation of wolframin expression in human placenta during pregnancy: comparison among physiological and pathological states.

Published

Journal Article

The WFS1 gene, encoding a transmembrane glycoprotein of the endoplasmic reticulum called wolframin, is mutated in Wolfram syndrome, an autosomal recessive disorder defined by the association of diabetes mellitus, optic atrophy, and further organ abnormalities. Disruption of the WFS1 gene in mice causes progressive β-cell loss in the pancreas and impaired stimulus-secretion coupling in insulin secretion. However, little is known about the physiological functions of this protein. We investigated the immunohistochemical expression of wolframin in human placenta throughout pregnancy in normal women and diabetic pregnant women. In normal placenta, there was a modulation of wolframin throughout pregnancy with a strong level of expression during the first trimester and a moderate level in the third trimester of gestation. In diabetic women, wolframin expression was strongly reduced in the third trimester of gestation. The pattern of expression of wolframin in normal placenta suggests that this protein may be required to sustain normal rates of cytotrophoblast cell proliferation during the first trimester of gestation. The decrease in wolframin expression in diabetic placenta suggests that this protein may participate in maintaining the physiologic glucose homeostasis in this organ.

Full Text

Duke Authors

Cited Authors

  • Lucariello, A; Perna, A; Sellitto, C; Baldi, A; Iannaccone, A; Cobellis, L; De Luca, A; De Falco, M

Published Date

  • 2014

Published In

Volume / Issue

  • 2014 /

Start / End Page

  • 985478 -

PubMed ID

  • 24588001

Pubmed Central ID

  • 24588001

Electronic International Standard Serial Number (EISSN)

  • 2314-6141

Digital Object Identifier (DOI)

  • 10.1155/2014/985478

Language

  • eng

Conference Location

  • United States